首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

1489179

全球 mRNA 治療市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global mRNA Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球 mRNA 治療市場需求預計將從 2023 年的 122.3 億美元達到近 498.2 億美元的市場規模，2024-2032 年研究期間複合年成長率為 16.89%。

mRNA 療法是一類利用信使 RNA (mRNA) 分子來引導細胞在體內產生治療性蛋白質或抗原的藥物。這些基於 mRNA 的藥物透過利用人體的天然蛋白質合成機制產生特定的治療分子，提供了一種治療疾病的新方法。這些藥物有望廣泛應用，包括疫苗、癌症免疫療法、蛋白質替代療法和再生醫學。

市場動態

人們對基於 mRNA 的藥物開發的興趣和投資不斷成長，推動了 mRNA 治療市場的發展。 mRNA 技術的多功能性和潛力可滿足未滿足的醫療需求，包括傳染病、癌症、遺傳性疾病和罕見疾病，推動了市場的成長。 mRNA 療法透過利用人體的天然蛋白質合成機制在細胞內產生治療性蛋白質或抗原，提供了一種新的藥物開發方法，實現有針對性和可客製化的治療策略。此外，mRNA 遞送系統、脂質奈米顆粒配方和 mRNA 穩定技術的進步提高了治療功效、生物利用度和安全性，推動了市場採用。

此外，基於 mRNA 的 COVID-19 疫苗的快速開發和監管批准證明了 mRNA 技術用於疫苗開發的可行性和可擴展性，從而加速了對其他疾病的 mRNA 療法的投資和研究。此外，製藥公司、生物技術公司、學術研究機構和政府機構之間的合作推動了 mRNA 藥物發現的創新和管道開發，進一步刺激了市場成長。然而，監管障礙、製造複雜性以及公眾對基因療法的看法擔憂可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球 mRNA 治療市場的各個細分市場進行了包容性評估。 mRNA 治療產業的成長和趨勢為本研究提供了整體方法。

市場區隔

mRNA 治療市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按申請

傳染性疾病
腫瘤學
罕見遺傳疾病
呼吸疾病
其他

按類型

預防性
治療性

按最終用途

醫院和診所
研究機構
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲 mRNA 治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。 mRNA治療市場的主要參與者包括Moderna Inc.、BioNTech SE、CureVac NV、Arcturus Therapeutics、賽諾菲、葛蘭素史克公司、Argos Therapeutics Inc.、Ethris、輝瑞公司、阿斯特捷利康。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：mRNA 治療公司的競爭格局

mRNA治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Moderna Inc.

公司簡介
公司收入
產品
最近的發展

BioNTech SE

公司簡介
公司收入
產品
最近的發展

CureVac NV

公司簡介
公司收入
產品
最近的發展

Arcturus Therapeutics

公司簡介
公司收入
產品
最近的發展

Sanofi

公司簡介
公司收入
產品
最近的發展

GSK Plc.

公司簡介
公司收入
產品
最近的發展

Argos Therapeutics Inc.

公司簡介
公司收入
產品
最近的發展

Ethris

公司簡介
公司收入
產品
最近的發展

Pfizer Inc.

公司簡介
公司收入
產品
最近的發展

AstraZeneca

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114584

The global demand for mRNA Therapeutics Market is presumed to reach the market size of nearly USD 49.82 Billion by 2032 from USD 12.23 Billion in 2023 with a CAGR of 16.89% under the study period 2024-2032.

mRNA therapeutics is a class of drugs that utilize messenger RNA (mRNA) molecules to instruct cells to produce therapeutic proteins or antigens within the body. These mRNA-based drugs offer a novel approach to treating diseases by harnessing the body's natural protein synthesis machinery to produce specific therapeutic molecules. These drugs hold promise for a wide range of applications, including vaccines, cancer immunotherapy, protein replacement therapy, and regenerative medicine.

MARKET DYNAMICS

The growing interest and investment in mRNA-based drug development drives the market for mRNA therapeutics. The versatility and potential of mRNA technology to address unmet medical needs, including infectious diseases, cancer, genetic disorders, and rare diseases, fuel market growth. mRNA therapeutics offer a novel approach to drug development by harnessing the body's natural protein synthesis machinery to produce therapeutic proteins or antigens within cells, enabling targeted and customizable treatment strategies. Moreover, advancements in mRNA delivery systems, lipid nanoparticle formulations, and mRNA stabilization techniques enhance therapeutic efficacy, bioavailability, and safety profiles, driving market adoption.

Additionally, the rapid development and regulatory approval of mRNA-based COVID-19 vaccines demonstrate the feasibility and scalability of mRNA technology for vaccine development, accelerating investment and research in mRNA therapeutics for other diseases. Furthermore, collaborations between pharmaceutical companies, biotechnology firms, academic research institutions, and government agencies propel innovation & pipeline development in mRNA drug discovery, further stimulating market growth. However, regulatory hurdles, manufacturing complexities, and public perception concerns regarding genetic therapies may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mRNA Therapeutics. The growth and trends of mRNA Therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the mRNA Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Infectious Diseases
Oncology
Rare Genetic Diseases
Respiratory Diseases
Others

By Type

Prophylactic
Therapeutic

By End-use

Hospitals & Clinics
Research Organizations
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the mRNA Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the mRNA Therapeutics market include Moderna Inc., BioNTech SE, CureVac N.V., Arcturus Therapeutics, Sanofi, GSK Plc., Argos Therapeutics Inc., Ethris, Pfizer Inc., AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MRNA THERAPEUTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MRNA THERAPEUTICS MARKET ANALYSIS BY APPLICATION

5.1. Overview By Application
5.2. Historical and Forecast Data
5.3. Analysis By Application
5.4. Infectious Diseases Historic and Forecast Sales By Regions
5.5. Oncology Historic and Forecast Sales By Regions
5.6. Rare Genetic Diseases Historic and Forecast Sales By Regions
5.7. Respiratory Diseases Historic and Forecast Sales By Regions
5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL MRNA THERAPEUTICS MARKET ANALYSIS BY TYPE

6.1. Overview By Type
6.2. Historical and Forecast Data
6.3. Analysis By Type
6.4. Prophylactic Historic and Forecast Sales By Regions
6.5. Therapeutic Historic and Forecast Sales By Regions

7. GLOBAL MRNA THERAPEUTICS MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data
7.3. Analysis By End-use
7.4. Hospitals & Clinics Historic and Forecast Sales By Regions
7.5. Research Organizations Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL MRNA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE MRNA THERAPEUTICS COMPANIES

9.1. MRNA Therapeutics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF MRNA THERAPEUTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Moderna Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. BioNTech SE
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. CureVac N.V.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Arcturus Therapeutics
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Sanofi
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. GSK Plc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Argos Therapeutics Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Ethris
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Pfizer Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. AstraZeneca
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments